Abstract:Objective To study the relations among insulin resistance,abnormality of serum leptin level soluble leptin receptor(sLR) and the development of fatty liver in type 2 diabetes mellitue (DFL), so as to detect the partial pathogenesis. Methods 196 patients with type 2 diabetes mellitus were selected to retrospective study. The DFL group consisted of 96 patients who had already developed to fatty liver, while the NDFL group included 100 patients with no fatty liver. Biochemical test and insulin resistance were analysisd, and the level of serum leptin and sLR were also examined. Results The level of blood triglyceride(TG), high density lipoprotein(HDL), very low density lipoprotein( VLDL) between two groups were all statistical differences (t = - 8.124, 4.882, - 3.576, P < 0.01). The TG, HDL and VLDL level in DFL group were (3.25 ± 1.92), (1.11 ±0.28), (1.53 ± 0.60) mmol/L respectively. There was also a statistical difference in HOMA-IR level between the two groups (t = - 4.748, P < 0.01). HOMA-IR in DFL group was (4.82± 2.94), but no statistical difference in secretive function of beta cells (t = 0.123, P > 0.05). There was statistical difference in level of serum leptin and sLR between the two groups (t = - 7.435,13.332, P < 0.01); the leptin and sLR in DFL group were (4.34± 2.05) and (1.71 ± 0.53) fig/L respectively. Meanwhile, Pearson analysis showed that the blood TG level of the DFL group was positively correlated with HOMA-IR and leptin ( r = 0.845, P< 0.01; r = 0.742, P< 0.01); serum leptin level was positively correlated with HOMA-IR level (r = 0.852, P<0.01). However, serum sLR level showed negative correlation ( r = - 0.587, P < 0.01). Conclusions Insulin resistance and abnormality serum level of leptin and sLR might be one of the important causes for DFL, while abnormal lipid metabolism might be the secondary cause for this biochemical change.

Association of Serum Phosphohpid Fatty Acids with Blood Lipid Profiles in Patients with Newly-Diagnosed Type 2 Diabetes Mellitus

Features of Serum Phospholipid Fatty Acids in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Association of Serum Phospholipid Fatty Acid and High-Sensitivity C Reactive Protein in Patients with Metabolic Syndrome and Type 2 Diabetes Mellitus

Serum Phospholipid Fatty Acid Spectrum and Its Correclation with Plasma Lipid in Patients with Type 2 Diabetes

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease

Relationship between Plasma Phospholipid Fatty Acid Profile and Insulin Resistance in Type 2 Diabetics

Association of Triglyceride with Serum Polyunsaturated Fatty Acid in Patients with Metabolic Syndrome

The Correlation between Serum Phospholipid Fatty Acids and Blood Lipids in Hypertension

Plasma Phospholipid Polyunsaturated Fatty Acids and Homocysteine in Chinese Type 2 Diabetes Patients

Serum phospholipid fatty acid profile in patients with obesity-related hypertension and non-obesity hypertension

Association of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes: Clinical Features and Independent Risk Factors in Diabetic Fatty Liver Patients.

Serum phospholipid fatty acid and insulin resistance in patients with metabolic syndrome

Study on the Relations Between Abnormality of Insulin Resistance, Serum Leptin and Fatty Liver in Type 2 Diabetes Mellitus

A study on the association between nonalcoholic fatty liver disease and the levels of sex hormones among patients with type 2 diabetes mellitus

Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial

Inverse Correlation Between Serum Adiponectin and 8-Iso-prostaglandin F2α in Newly Diagnosed Type 2 Diabetes Patients.

Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China.

Serum bile acid and unsaturated fatty acid profiles of non-alcoholic fatty liver disease in type 2 diabetic patients

[Serum Omega-3 Polyunsaturated Fatty Acid and Insulin Resistance in Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease].

Low Docosahexaenoic Acid Content in Plasma Phospholipids is Associated with Increased Non-alcoholic Fatty Liver Disease in China